We are live on ! Find out more
THP

Tower House Partners Portfolio holdings

AUM $16.8M
1-Year Est. Return 41.98%
This Fund
S&P 500
This Quarter Est. Return
-25.81%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$52.2M
AUM Growth
–
Cap. Flow
+$60.4M
Cap. Flow %
115.54%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$60.4M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIO icon
1
Bio-Rad Laboratories Class A
BIO
$8.05B
$52.2M 100%
+225,000
New +$60.4M

Similar funds

RCGV
Ribbit Capital GP V Palo Alto, California $19.8M AUM
SCM
Stamina Capital Management New York $13.3M AUM 71.17% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
OHU
Odey Holdings (UK) London, United Kingdom $12.4M AUM 20.7% 1-Year Est. Return
OA
Oakhurst Advisors Los Angeles, California $21.3M AUM 8.8% 1-Year Est. Return
JM
Jeneq Management New York $22.3M AUM 47.87% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Tower House Partners's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Tower House Partners, which disclosed 1 position worth $52.2M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Bio-Rad Laboratories Class A: 225,000 shares worth $52.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Tower House Partners's largest Q4 2018 buy was Bio-Rad Laboratories Class A: 225,000 shares worth $52.2M.
  • Tower House Partners's ten largest holdings make up 100% of its $52.2M portfolio in Q4 2018.
  • Tower House Partners disclosed 1 position in Q4 2018, its first 13F filing on record.

Based on Tower House Partners's 13F filing for Q4 2018, filed 13 Feb 2019.